Table 2.
Characteristics | PITC* median (IQR) or N (%) | VCT** median (IQR) or N (%) | p |
---|---|---|---|
Age | N=2239 | N=9730 | |
At enrolment | 32.0 (26.0–39.0) | 32.0 (26.0–38.0) | 0.5429^ |
≤15 | 225 (10.0%) | 719 (7.4%) | <0.0001^^ |
16–35 | 1193 (53.3%) | 5617 (57.7%) | . |
36+ | 821 (36.7%) | 3394 (34.9%) | . |
Sex | N=2239 | N=9730 | |
Female | 1261 (56.3%) | 5868 (60.0%) | 0.0005^^ |
Male | 978 (43.7%) | 3862 (40.0%) | . |
N=1998 | N=8506 | ||
CD4 (cells/µL) at enrolment | 224 (110.0–387.0) | 264 (137.0–427.0) | <0.0001^ |
≤50 | 223 (11.2%) | 701 (8.3%) | <0.0001^^ |
51–199 | 676 (33.8%) | 2561 (30.1%) | . |
200–349 | 514 (25.7%) | 2195 (25.8%) | . |
≥350 | 585 (29.3%) | 3049 (35.8%) | . |
N=1932 | N=8602 | ||
BMI (kg/m2) at enrolment | 20.0 (18.1–22.2) | 20.4 (18.4–22.8) | <0.0001^ |
<18.5 | 559 (28.9%) | 2196 (25.5%) | <0.001^^ |
18.5–24.99 | 1180 (61.1%) | 5357 (62.3%) | . |
≥25 | 193 (10.0%) | 1049 (12.2%) | . |
N=1951 | N=8339 | ||
HBG (g/dL) at enrolment | 11.2 (9.7–12.6) | 11.7 (10.1–13.2) | <0.0001^ |
≤8 | 163 (8.4%) | 539 (6.5%) | <0.0001^^ |
8.1–9.9 | 388 (19.9%) | 1420 (17.0%) | . |
≥10 | 1400 (71.8%) | 6380 (76.5%) | . |
Active TB at enrolment | N=2239 | N=9730 | |
Yes | 113 (5.0%) | 99 (1.0%) | <0.0001^^ |
No | 2126 (95.0%) | 9631 (99.0%) | . |
Education | N=2234 | N=9092 | |
None | 809 (36.2%) | 2503 (27.5%) | <0.0001^^ |
Primary | 674 (30.2%) | 2919 (32.1%) | . |
Secondary and tertiary | 751 (33.6%) | 3670 (40.4%) | . |
Partner HIV status | N=2239 | N=9730 | |
Negative | 93 (4.2%) | 500 (5.1%) | <0.0001^^ |
Positive | 376 (16.8%) | 2611 (26.8%) | . |
Unknown/missing | 1770 (79.1%) | 6619 (68.0%) | . |
PITC=Clients who tested positive to HIV in provider-initiated testing services available in an integrated clinic and subsequently enrolled in HIV care up to study cut-off date.
VCT=Clients who tested positive to HIV in any (on-site or off-site) voluntary HIV testing services and enrolled in HIV care in an integrated clinic, up to study cut-off date.
Wilcoxon rank-sum tests.
Pearson's Chi-square test.